{"entity":{"type":"insider","cik":"0001744749","url":"/insider/0001744749","json_url":"/insider/0001744749.json","name":"Biller Jonathan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":11,"first":"2023-10-03","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Biller Jonathan","source":"filing","n_filings":11,"first_seen":"2023-10-03","last_seen":"2026-02-26"}],"transactions":[{"id":6145542,"accession":"0000875320-26-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000108","line_url":"/filing/0000875320-26-000108#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":945.0,"shares_display":"945","price_per_share":486.35,"price_display":"486.35","price_state":"stated","total_value":459600.75,"total_display":"459,600.75","total_whole":"459,601","shares_owned_after":13659.0,"shares_owned_after_display":"13,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":5804637,"accession":"0000875320-26-000084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000875320-26-000084","line_url":"/filing/0000875320-26-000084#line-4","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1244.0,"shares_display":"1,244","price_per_share":473.68,"price_display":"473.68","price_state":"stated","total_value":589257.92,"total_display":"589,257.92","total_whole":"589,258","shares_owned_after":15748.0,"shares_owned_after_display":"15,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider"},{"id":5804635,"accession":"0000875320-26-000084","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-26-000084","line_url":"/filing/0000875320-26-000084#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2476.0,"shares_display":"2,476","price_per_share":489.46,"price_display":"489.46","price_state":"stated","total_value":1211902.96,"total_display":"1,211,902.96","total_whole":"1,211,903","shares_owned_after":16992.0,"shares_owned_after_display":"16,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":5974352,"accession":"0000875320-26-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000064","line_url":"/filing/0000875320-26-000064#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":988.0,"shares_display":"988","price_per_share":499.0,"price_display":"499.00","price_state":"stated","total_value":493012.0,"total_display":"493,012.00","total_whole":"493,012","shares_owned_after":16838.0,"shares_owned_after_display":"16,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":6012629,"accession":"0000875320-26-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-26-000040","line_url":"/filing/0000875320-26-000040#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1925.0,"shares_display":"1,925","price_per_share":460.43,"price_display":"460.43","price_state":"stated","total_value":886327.75,"total_display":"886,327.75","total_whole":"886,328","shares_owned_after":20819.0,"shares_owned_after_display":"20,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":4161576,"accession":"0000875320-25-000240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-25-000240","line_url":"/filing/0000875320-25-000240#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":449.0,"price_display":"449.00","price_state":"stated","total_value":155803.0,"total_display":"155,803.00","total_whole":"155,803","shares_owned_after":15306.0,"shares_owned_after_display":"15,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider"},{"id":4126172,"accession":"0000875320-25-000224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000224","line_url":"/filing/0000875320-25-000224#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":694.0,"shares_display":"694","price_per_share":404.21,"price_display":"404.21","price_state":"stated","total_value":280521.74,"total_display":"280,521.74","total_whole":"280,522","shares_owned_after":15653.0,"shares_owned_after_display":"15,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4405925,"accession":"0000875320-25-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000085","line_url":"/filing/0000875320-25-000085#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1657.0,"shares_display":"1,657","price_per_share":455.06,"price_display":"455.06","price_state":"stated","total_value":754034.42,"total_display":"754,034.42","total_whole":"754,034","shares_owned_after":17606.0,"shares_owned_after_display":"17,606","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":5148239,"accession":"0000875320-25-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000039","line_url":"/filing/0000875320-25-000039#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3433.0,"shares_display":"3,433","price_per_share":459.87,"price_display":"459.87","price_state":"stated","total_value":1578733.71,"total_display":"1,578,733.71","total_whole":"1,578,734","shares_owned_after":16330.0,"shares_owned_after_display":"16,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":2941213,"accession":"0000875320-24-000214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000214","line_url":"/filing/0000875320-24-000214#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":999.0,"shares_display":"999","price_per_share":461.66,"price_display":"461.66","price_state":"stated","total_value":461198.34,"total_display":"461,198.34","total_whole":"461,198","shares_owned_after":16651.0,"shares_owned_after_display":"16,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-03","scope":"insider"},{"id":2200507,"accession":"0000875320-24-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000047","line_url":"/filing/0000875320-24-000047#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1738.0,"shares_display":"1,738","price_per_share":418.77,"price_display":"418.77","price_state":"stated","total_value":727822.26,"total_display":"727,822.26","total_whole":"727,822","shares_owned_after":18280.0,"shares_owned_after_display":"18,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":8023427,"accession":"0001209191-23-051408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-051408","line_url":"/filing/0001209191-23-051408#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001744749","owner_name":"Biller Jonathan","owner_display_name":"Biller Jonathan","owner_url":"/insider/0001744749","role":"Officer (EVP and Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP and Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":610.0,"shares_display":"610","price_per_share":346.76,"price_display":"346.76","price_state":"stated","total_value":211523.6,"total_display":"211,523.60","total_whole":"211,524","shares_owned_after":10569.0,"shares_owned_after_display":"10,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP and Chief Legal Officer)","n_filings":11,"first_seen":"2023-10-03","last_seen":"2026-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744749","retrieved_at":"2026-08-22T09:30:28+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}